| 标题 |
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2) |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Kim Papp; Richard G. Langley; Mark Lebwohl; Gerald G. Krueger; Philippe Szapary; et al 出版日期:2008-05-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)